Endocrine Disorders: Evaluation and Management
Summary
- Pramlintide is approved for use in type 1 or insulin-treated type 2 diabetes patients not achieving adequate control with basal and prandial insulin
Action required
- Login now to access all of your entitled content
or - View additional options to gain access to this content
Keywords: Diabetes, Endocrine Disorders